Report Detail
Global Pressurized Metered Dose Inhaler Supply, Demand and Key Producers, 2026-2032
- RnM4667857 |
- 22 January, 2026 |
- Global |
- 101 Pages |
- GIR |
- Medical Devices & Consumables
The global Pressurized Metered Dose Inhaler market size is expected to reach $ 8648 million by 2032, rising at a market growth of 3.4% CAGR during the forecast period (2026-2032).
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report studies the global Pressurized Metered Dose Inhaler production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pressurized Metered Dose Inhaler and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pressurized Metered Dose Inhaler that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pressurized Metered Dose Inhaler total production and demand, 2021-2032, (M Units)
Global Pressurized Metered Dose Inhaler total production value, 2021-2032, (USD Million)
Global Pressurized Metered Dose Inhaler production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Pressurized Metered Dose Inhaler consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Pressurized Metered Dose Inhaler domestic production, consumption, key domestic manufacturers and share
Global Pressurized Metered Dose Inhaler production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Pressurized Metered Dose Inhaler production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Pressurized Metered Dose Inhaler production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Pressurized Metered Dose Inhaler market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, Teva, Merck & Co. Inc, Boehringer Ingelheim, Mylan, Arkon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pressurized Metered Dose Inhaler market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pressurized Metered Dose Inhaler Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pressurized Metered Dose Inhaler Market, Segmentation by Type:
Manual Pressurized Metered Dose Inhaler
Smart Pressurized Metered Dose Inhaler
Global Pressurized Metered Dose Inhaler Market, Segmentation by Application:
Asthma
COPD
Others
Companies Profiled:
GlaxoSmithKline
Chiesi Farmaceutici S.p.A
AstraZeneca
Teva
Merck & Co. Inc
Boehringer Ingelheim
Mylan
Arkon
Key Questions Answered:
1. How big is the global Pressurized Metered Dose Inhaler market?
2. What is the demand of the global Pressurized Metered Dose Inhaler market?
3. What is the year over year growth of the global Pressurized Metered Dose Inhaler market?
4. What is the production and production value of the global Pressurized Metered Dose Inhaler market?
5. Who are the key producers in the global Pressurized Metered Dose Inhaler market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Pressurized Metered Dose Inhaler Introduction
- 1.2 World Pressurized Metered Dose Inhaler Supply & Forecast
- 1.2.1 World Pressurized Metered Dose Inhaler Production Value (2021 & 2025 & 2032)
- 1.2.2 World Pressurized Metered Dose Inhaler Production (2021-2032)
- 1.2.3 World Pressurized Metered Dose Inhaler Pricing Trends (2021-2032)
- 1.3 World Pressurized Metered Dose Inhaler Production by Region (Based on Production Site)
- 1.3.1 World Pressurized Metered Dose Inhaler Production Value by Region (2021-2032)
- 1.3.2 World Pressurized Metered Dose Inhaler Production by Region (2021-2032)
- 1.3.3 World Pressurized Metered Dose Inhaler Average Price by Region (2021-2032)
- 1.3.4 North America Pressurized Metered Dose Inhaler Production (2021-2032)
- 1.3.5 Europe Pressurized Metered Dose Inhaler Production (2021-2032)
- 1.3.6 Israel Pressurized Metered Dose Inhaler Production (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Pressurized Metered Dose Inhaler Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Pressurized Metered Dose Inhaler Major Market Trends
2 Demand Summary
- 2.1 World Pressurized Metered Dose Inhaler Demand (2021-2032)
- 2.2 World Pressurized Metered Dose Inhaler Consumption by Region
- 2.2.1 World Pressurized Metered Dose Inhaler Consumption by Region (2021-2026)
- 2.2.2 World Pressurized Metered Dose Inhaler Consumption Forecast by Region (2027-2032)
- 2.3 United States Pressurized Metered Dose Inhaler Consumption (2021-2032)
- 2.4 China Pressurized Metered Dose Inhaler Consumption (2021-2032)
- 2.5 Europe Pressurized Metered Dose Inhaler Consumption (2021-2032)
- 2.6 Japan Pressurized Metered Dose Inhaler Consumption (2021-2032)
- 2.7 South Korea Pressurized Metered Dose Inhaler Consumption (2021-2032)
- 2.8 ASEAN Pressurized Metered Dose Inhaler Consumption (2021-2032)
- 2.9 India Pressurized Metered Dose Inhaler Consumption (2021-2032)
3 World Manufacturers Competitive Analysis
- 3.1 World Pressurized Metered Dose Inhaler Production Value by Manufacturer (2021-2026)
- 3.2 World Pressurized Metered Dose Inhaler Production by Manufacturer (2021-2026)
- 3.3 World Pressurized Metered Dose Inhaler Average Price by Manufacturer (2021-2026)
- 3.4 Pressurized Metered Dose Inhaler Company Evaluation Quadrant
- 3.5 Industry Rank and Concentration Rate (CR)
- 3.5.1 Global Pressurized Metered Dose Inhaler Industry Rank of Major Manufacturers
- 3.5.2 Global Concentration Ratios (CR4) for Pressurized Metered Dose Inhaler in 2025
- 3.5.3 Global Concentration Ratios (CR8) for Pressurized Metered Dose Inhaler in 2025
- 3.6 Pressurized Metered Dose Inhaler Market: Overall Company Footprint Analysis
- 3.6.1 Pressurized Metered Dose Inhaler Market: Region Footprint
- 3.6.2 Pressurized Metered Dose Inhaler Market: Company Product Type Footprint
- 3.6.3 Pressurized Metered Dose Inhaler Market: Company Product Application Footprint
- 3.7 Competitive Environment
- 3.7.1 Historical Structure of the Industry
- 3.7.2 Barriers of Market Entry
- 3.7.3 Factors of Competition
- 3.8 New Entrant and Capacity Expansion Plans
- 3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
- 4.1 United States VS China: Pressurized Metered Dose Inhaler Production Value Comparison
- 4.1.1 United States VS China: Pressurized Metered Dose Inhaler Production Value Comparison (2021 & 2025 & 2032)
- 4.1.2 United States VS China: Pressurized Metered Dose Inhaler Production Value Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States VS China: Pressurized Metered Dose Inhaler Production Comparison
- 4.2.1 United States VS China: Pressurized Metered Dose Inhaler Production Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Pressurized Metered Dose Inhaler Production Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States VS China: Pressurized Metered Dose Inhaler Consumption Comparison
- 4.3.1 United States VS China: Pressurized Metered Dose Inhaler Consumption Comparison (2021 & 2025 & 2032)
- 4.3.2 United States VS China: Pressurized Metered Dose Inhaler Consumption Market Share Comparison (2021 & 2025 & 2032)
- 4.4 United States Based Pressurized Metered Dose Inhaler Manufacturers and Market Share, 2021-2026
- 4.4.1 United States Based Pressurized Metered Dose Inhaler Manufacturers, Headquarters and Production Site (States, Country)
- 4.4.2 United States Based Manufacturers Pressurized Metered Dose Inhaler Production Value (2021-2026)
- 4.4.3 United States Based Manufacturers Pressurized Metered Dose Inhaler Production (2021-2026)
- 4.5 China Based Pressurized Metered Dose Inhaler Manufacturers and Market Share
- 4.5.1 China Based Pressurized Metered Dose Inhaler Manufacturers, Headquarters and Production Site (Province, Country)
- 4.5.2 China Based Manufacturers Pressurized Metered Dose Inhaler Production Value (2021-2026)
- 4.5.3 China Based Manufacturers Pressurized Metered Dose Inhaler Production (2021-2026)
- 4.6 Rest of World Based Pressurized Metered Dose Inhaler Manufacturers and Market Share, 2021-2026
- 4.6.1 Rest of World Based Pressurized Metered Dose Inhaler Manufacturers, Headquarters and Production Site (State, Country)
- 4.6.2 Rest of World Based Manufacturers Pressurized Metered Dose Inhaler Production Value (2021-2026)
- 4.6.3 Rest of World Based Manufacturers Pressurized Metered Dose Inhaler Production (2021-2026)
5 Market Analysis by Type
- 5.1 World Pressurized Metered Dose Inhaler Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 Manual Pressurized Metered Dose Inhaler
- 5.2.2 Smart Pressurized Metered Dose Inhaler
- 5.3 Market Segment by Type
- 5.3.1 World Pressurized Metered Dose Inhaler Production by Type (2021-2032)
- 5.3.2 World Pressurized Metered Dose Inhaler Production Value by Type (2021-2032)
- 5.3.3 World Pressurized Metered Dose Inhaler Average Price by Type (2021-2032)
6 Market Analysis by Application
- 6.1 World Pressurized Metered Dose Inhaler Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Asthma
- 6.2.2 COPD
- 6.2.3 Others
- 6.3 Market Segment by Application
- 6.3.1 World Pressurized Metered Dose Inhaler Production by Application (2021-2032)
- 6.3.2 World Pressurized Metered Dose Inhaler Production Value by Application (2021-2032)
- 6.3.3 World Pressurized Metered Dose Inhaler Average Price by Application (2021-2032)
7 Company Profiles
- 7.1 GlaxoSmithKline
- 7.1.1 GlaxoSmithKline Details
- 7.1.2 GlaxoSmithKline Major Business
- 7.1.3 GlaxoSmithKline Pressurized Metered Dose Inhaler Product and Services
- 7.1.4 GlaxoSmithKline Pressurized Metered Dose Inhaler Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.1.5 GlaxoSmithKline Recent Developments/Updates
- 7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
- 7.2 Chiesi Farmaceutici S.p.A
- 7.2.1 Chiesi Farmaceutici S.p.A Details
- 7.2.2 Chiesi Farmaceutici S.p.A Major Business
- 7.2.3 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product and Services
- 7.2.4 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.2.5 Chiesi Farmaceutici S.p.A Recent Developments/Updates
- 7.2.6 Chiesi Farmaceutici S.p.A Competitive Strengths & Weaknesses
- 7.3 AstraZeneca
- 7.3.1 AstraZeneca Details
- 7.3.2 AstraZeneca Major Business
- 7.3.3 AstraZeneca Pressurized Metered Dose Inhaler Product and Services
- 7.3.4 AstraZeneca Pressurized Metered Dose Inhaler Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.3.5 AstraZeneca Recent Developments/Updates
- 7.3.6 AstraZeneca Competitive Strengths & Weaknesses
- 7.4 Teva
- 7.4.1 Teva Details
- 7.4.2 Teva Major Business
- 7.4.3 Teva Pressurized Metered Dose Inhaler Product and Services
- 7.4.4 Teva Pressurized Metered Dose Inhaler Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.4.5 Teva Recent Developments/Updates
- 7.4.6 Teva Competitive Strengths & Weaknesses
- 7.5 Merck & Co. Inc
- 7.5.1 Merck & Co. Inc Details
- 7.5.2 Merck & Co. Inc Major Business
- 7.5.3 Merck & Co. Inc Pressurized Metered Dose Inhaler Product and Services
- 7.5.4 Merck & Co. Inc Pressurized Metered Dose Inhaler Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.5.5 Merck & Co. Inc Recent Developments/Updates
- 7.5.6 Merck & Co. Inc Competitive Strengths & Weaknesses
- 7.6 Boehringer Ingelheim
- 7.6.1 Boehringer Ingelheim Details
- 7.6.2 Boehringer Ingelheim Major Business
- 7.6.3 Boehringer Ingelheim Pressurized Metered Dose Inhaler Product and Services
- 7.6.4 Boehringer Ingelheim Pressurized Metered Dose Inhaler Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.6.5 Boehringer Ingelheim Recent Developments/Updates
- 7.6.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
- 7.7 Mylan
- 7.7.1 Mylan Details
- 7.7.2 Mylan Major Business
- 7.7.3 Mylan Pressurized Metered Dose Inhaler Product and Services
- 7.7.4 Mylan Pressurized Metered Dose Inhaler Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.7.5 Mylan Recent Developments/Updates
- 7.7.6 Mylan Competitive Strengths & Weaknesses
- 7.8 Arkon
- 7.8.1 Arkon Details
- 7.8.2 Arkon Major Business
- 7.8.3 Arkon Pressurized Metered Dose Inhaler Product and Services
- 7.8.4 Arkon Pressurized Metered Dose Inhaler Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.8.5 Arkon Recent Developments/Updates
- 7.8.6 Arkon Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Pressurized Metered Dose Inhaler Industry Chain
- 8.2 Pressurized Metered Dose Inhaler Upstream Analysis
- 8.2.1 Pressurized Metered Dose Inhaler Core Raw Materials
- 8.2.2 Main Manufacturers of Pressurized Metered Dose Inhaler Core Raw Materials
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis
- 8.5 Pressurized Metered Dose Inhaler Production Mode
- 8.6 Pressurized Metered Dose Inhaler Procurement Model
- 8.7 Pressurized Metered Dose Inhaler Industry Sales Model and Sales Channels
- 8.7.1 Pressurized Metered Dose Inhaler Sales Model
- 8.7.2 Pressurized Metered Dose Inhaler Typical Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pressurized Metered Dose Inhaler. Industry analysis & Market Report on Pressurized Metered Dose Inhaler is a syndicated market report, published as Global Pressurized Metered Dose Inhaler Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Pressurized Metered Dose Inhaler market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
